Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.38 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11884468 | 0.97 | MEN1 (0.54) | MEN1KMT2AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL17586275 | 0.97 | — | — | |
| SCHEMBL25799601 | 0.94 | MEN1 (0.56) | MEN1KMT2AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL25799592 | 0.87 | MEN1 (0.47) | MEN1KMT2AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL1644239 | 0.83 | GRIN2D (0.42) | MEN1KMT2AGRIN2DGRIN3BGRIN1 | |
| Hydrochloric Acid SCHEMBL1642487 | 0.79 | GRIN2D (0.40) | MEN1KMT2AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL19242576 | 0.75 | — | — | |
| SCHEMBL22733059 | 0.73 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL17586269 | 0.73 | — | — | |
| SCHEMBL21618340 | 0.69 | GRIN2D (0.38) | MEN1KMT2AGRIN2DGRIN3BGRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110200536-A1 | CHELATORS, PARAMAGNETIC CHELATES THEREOF AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | GE HEALTHCARE AS (NO) | 2011-08-18 | — | — | US | disclosed |
| US-20100008864-A1 | AROMATIC MULTIMERS | MEIJER ANDREAS | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100008864-A1 | AROMATIC MULTIMERS | AHR, ARG2, PAH | MEN1 385/4885KMT2A 2055/4885GRIN2D 2112/4885 |
| US-20110200536-A1 | CHELATORS, PARAMAGNETIC CHELATES THEREOF AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | TSPO, PML, AIP | MEN1 575/4885KMT2A 1119/4885GRIN2D 3841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.